U-Chart Analysis:Nissui Pharmaceutical Co.,Ltd.:4550

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nissui Pharmaceutical Co.,Ltd. Go to web site 4550 Medicals 東証プライム March 1, 2000 1990.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Nissui Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2022年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2021年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2019年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2018年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Cash and Cash Equivalents 4,807 4,461 3,462 2,401 7,565
Other Current AssetsHelp 27,141 25,923 25,041 27,005 21,401
Tangible Fixed AssetsHelp 3,207 3,274 4,962 3,848 3,893
Intangible Fixed AssetHelp 114 77 101 109 111
Investments and OthersHelp 1,655 2,066 1,637 2,538 2,839
Total AssetsHelp 36,924 35,801 35,203 35,901 35,809
Total Current LiabilitiesHelp 4,229 3,321 3,026 3,044 2,767
Total Long-term LiabilitiesHelp 90 8 1 30 68
Shareholder's EquityHelp 32,605 32,472 32,176 32,827 32,974
Total LiabilitiesHelp 36,924 35,801 35,203 35,901 35,809

Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2019年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2018年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Amount of Sales 16,657 11,971 12,773 12,549 12,329
Total Sales 16,657 11,971 12,773 12,549 12,329
Cost of SalesHelp 11,399 7,871 7,047 6,791 6,476
Other Costs and RevenueHelp 4,112 3,444 5,324 4,973 4,677
Total CostsHelp 15,511 11,315 12,371 11,764 11,153
Net RevenueHelp 5,258 4,100 5,726 5,758 5,853
Earnings Before TaxHelp 1,649 943 642 1,382 1,691
Net IncomeHelp 1,146 656 402 785 1,176
Net Income 1,146 656 402 785 1,176

Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2019年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2018年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Operating Cash Flow(OFC)Help 1,007 505 1,495 1,363 865
Investing Cash Flow(ICF)Help 361 938 -1,940 -10,527 362
Financing Cash FlowHelp -1,010 -476 -931 -930 -929
Exchange Difference of Cash and Cash EquivalentsHelp 11 0 0 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn 369 967 -1,376 -10,094 298

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nissui Pharmaceutical Co.,Ltd.

Company where related level is highHelp

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Nxera Pharma Co., Ltd.
Renascience Inc.
HEALIOS K.K.
EIKEN CHEMICAL CO.,LTD.
KAINOS Laboratories,Inc.
KAKEN PHARMACEUTICAL CO.,LTD.
Kubota Pharmaceutical Holdings Co.,Ltd.
ROHTO PHARMACEUTICAL CO.,LTD.
Noile-Immune Biotech Inc.